EP2136638A4 - Modifizierte freisetzungsformulierungen von (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazoldiamin und verwendungsverfahren - Google Patents
Modifizierte freisetzungsformulierungen von (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazoldiamin und verwendungsverfahrenInfo
- Publication number
- EP2136638A4 EP2136638A4 EP08743922A EP08743922A EP2136638A4 EP 2136638 A4 EP2136638 A4 EP 2136638A4 EP 08743922 A EP08743922 A EP 08743922A EP 08743922 A EP08743922 A EP 08743922A EP 2136638 A4 EP2136638 A4 EP 2136638A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- benzothiazole
- tetrahydro
- diamine
- propyl
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89483507P | 2007-03-14 | 2007-03-14 | |
US89482907P | 2007-03-14 | 2007-03-14 | |
US89479907P | 2007-03-14 | 2007-03-14 | |
US89481407P | 2007-03-14 | 2007-03-14 | |
US97904907P | 2007-10-10 | 2007-10-10 | |
US11/957,157 US8518926B2 (en) | 2006-04-10 | 2007-12-14 | Compositions and methods of using (R)-pramipexole |
PCT/US2008/057059 WO2008113003A1 (en) | 2007-03-14 | 2008-03-14 | Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2136638A1 EP2136638A1 (de) | 2009-12-30 |
EP2136638A4 true EP2136638A4 (de) | 2010-05-12 |
Family
ID=39760090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08743922A Withdrawn EP2136638A4 (de) | 2007-03-14 | 2008-03-14 | Modifizierte freisetzungsformulierungen von (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazoldiamin und verwendungsverfahren |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2136638A4 (de) |
JP (1) | JP2010521493A (de) |
CN (1) | CN101677564A (de) |
AU (1) | AU2008224869A1 (de) |
CA (1) | CA2680800A1 (de) |
WO (1) | WO2008113003A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8518926B2 (en) | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
PL2026803T3 (pl) | 2006-05-16 | 2012-05-31 | Knopp Neurosciences Inc | Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania |
US8524695B2 (en) | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
CA2681110A1 (en) | 2007-03-14 | 2008-09-18 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
CA2734491A1 (en) | 2008-08-19 | 2010-02-25 | Knopp Neurosciences, Inc. | Compositions and methods of using (r)-pramipexole |
WO2010115267A1 (en) * | 2009-04-09 | 2010-10-14 | Purdue Pharma | Once-daily oral ir/cr pramipexole formulation |
EP2442655A4 (de) * | 2009-06-19 | 2013-04-03 | Knopp Neurosciences Inc | Zusammensetzungen und verfahren zur behandlung von amyotropher lateralsklerose (als) |
DK2493296T3 (en) | 2009-10-30 | 2019-04-15 | Retrotope Inc | REMOVAL OF OXIDATIVE STRESS STATES WITH PUFA DERIVATIVES |
EP2701695B1 (de) | 2011-04-26 | 2019-04-03 | Retrotope, Inc. | Neurodegenerative erkrankungen und muskelerkrankungen mit polyungesättigten fettsäuren |
EP3730135A1 (de) | 2011-04-26 | 2020-10-28 | Retrotope, Inc. | Erkrankungen aufgrund gestörter energieverarbeitung und mitochondrienmangel |
WO2012148930A2 (en) | 2011-04-26 | 2012-11-01 | Retrotope, Inc. | Oxidative retinal diseases |
ES2859753T3 (es) | 2011-04-26 | 2021-10-04 | Retrotope Inc | Trastornos que implican la oxidación de PUFA |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
WO2013096870A1 (en) * | 2011-12-22 | 2013-06-27 | Knopp Neurosciences Inc | Compositions and methods for treating amyotrophic lateral sclerosis |
US20140045801A1 (en) * | 2012-08-09 | 2014-02-13 | Mylan Inc. | Pramipexole transdermal delivery for severe headaches |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
WO2015006708A1 (en) | 2013-07-12 | 2015-01-15 | Knopp Biosciences Llc | Treating elevated levels of eosinophils and/or basophils |
US9642840B2 (en) | 2013-08-13 | 2017-05-09 | Knopp Biosciences, Llc | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders |
AU2014306597B2 (en) | 2013-08-13 | 2018-05-17 | Knopp Biosciences Llc | Compositions and methods for treating chronic urticaria |
EP3858843A1 (de) | 2015-11-23 | 2021-08-04 | Retrotope, Inc. | Ortsspezifische isotopische markierung von 1,4-dien-systemen |
KR20200002899A (ko) | 2017-04-10 | 2020-01-08 | 체이스 테라퓨틱스 코포레이션 | 시누클레인병변을 치료하기 위한 nk1-길항제 배합물 및 방법 |
US11779910B2 (en) | 2020-02-21 | 2023-10-10 | Biojiva Llc | Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005011687A1 (de) * | 2003-07-23 | 2005-02-10 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches system mit dem wirkstoff pramipexol |
WO2006015943A2 (en) * | 2004-08-13 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
WO2007137071A2 (en) * | 2006-05-16 | 2007-11-29 | Knopp Neurosciences, Inc. | Compositions of r(+) and s(-) pramipexole and methods of using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060281797A1 (en) * | 2001-12-11 | 2006-12-14 | University Of Virginia Patent Foundation | Neurorestoration with R(+) Pramipexole |
CN1617720A (zh) * | 2001-12-11 | 2005-05-18 | 弗吉尼亚大学专利基金会 | 普拉克索用于治疗肌萎缩性侧索硬化的用途 |
CA2619217A1 (en) * | 2005-08-15 | 2007-02-22 | University Of Virginia Patent Foundation | Neurorestoration with r(+) pramipexole |
-
2008
- 2008-03-14 AU AU2008224869A patent/AU2008224869A1/en not_active Abandoned
- 2008-03-14 CN CN200880015896A patent/CN101677564A/zh active Pending
- 2008-03-14 EP EP08743922A patent/EP2136638A4/de not_active Withdrawn
- 2008-03-14 JP JP2009553814A patent/JP2010521493A/ja active Pending
- 2008-03-14 CA CA002680800A patent/CA2680800A1/en not_active Abandoned
- 2008-03-14 WO PCT/US2008/057059 patent/WO2008113003A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005011687A1 (de) * | 2003-07-23 | 2005-02-10 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches system mit dem wirkstoff pramipexol |
WO2006015943A2 (en) * | 2004-08-13 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
WO2007137071A2 (en) * | 2006-05-16 | 2007-11-29 | Knopp Neurosciences, Inc. | Compositions of r(+) and s(-) pramipexole and methods of using the same |
Non-Patent Citations (1)
Title |
---|
See also references of WO2008113003A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2136638A1 (de) | 2009-12-30 |
CA2680800A1 (en) | 2008-09-18 |
AU2008224869A1 (en) | 2008-09-18 |
JP2010521493A (ja) | 2010-06-24 |
CN101677564A (zh) | 2010-03-24 |
WO2008113003A1 (en) | 2008-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2136638A4 (de) | Modifizierte freisetzungsformulierungen von (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazoldiamin und verwendungsverfahren | |
HRP20190378T1 (hr) | Prolijekovi tetrahidrokanabinola, pripravci koji sadržavaju prolijekove tetrahidrokanabinola i postupci za njihovu uporabu | |
EP2043647A4 (de) | Formulierung mit gesteuerter freisetzung und entsprechende verfahren | |
HK1218427A1 (zh) | 改進的疫苗及其使用方法 | |
EP2066350A4 (de) | Stabilisierte antikörper-formulierungen und deren verwendungen | |
AU2013201592A1 (en) | Improved vaccines and methods for using the same | |
GB2443287B (en) | Methods, compositions and formulations for the treatment of thyroid eye disease | |
IL214183A (en) | Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation | |
EP2209756A4 (de) | Agrarzusammensetzungen und verfahren zu ihrer herstellung und verwendung | |
ZA200802602B (en) | Controlled release formulation | |
EP2152304A4 (de) | Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür | |
HK1213814A1 (zh) | 雙氯芬酸製劑和使用方法 | |
EP1883406A4 (de) | Zusammensetzungen und verfahren zur anhaltenden freisetzung von beta-alanin | |
EP1877068A4 (de) | Nicotinamidribosid-kinase-zusammensetzungen und verfahren zu deren verwendung | |
ZA200808431B (en) | Fungicidal compositions and methods of using the same | |
PL2057153T3 (pl) | POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINY | |
IL195528A (en) | Pyridazine compound, methods of preparation, a pharmaceutical composition containing it, its use and intermediate material | |
EP2086317A4 (de) | Nikotinformulierungen, kits und systeme und verfahren zu ihrer verwendung | |
HK1131140A1 (en) | Substituted prolinamides, and the use thereof | |
EP2018101A4 (de) | Siliciumtensid-basierte formulierungen zur anwendung in der landwirtschaft und verfahren zu ihrer verwendung | |
EP2101737A4 (de) | Revaprazan enthaltende feste dispersion und verfahren zu ihrer herstellung | |
IL184834A0 (en) | Compositions and methods for the manufacture thereof | |
IL185723A0 (en) | Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same | |
IL177328A0 (en) | Controlled release formulations | |
IL201959A0 (en) | Pyrazolone derivatives, compositions comprising the same and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20091013 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100414 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/16 20060101ALI20100408BHEP Ipc: A61K 31/428 20060101AFI20100408BHEP |
|
17Q | First examination report despatched |
Effective date: 20110708 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20141001 |